93 Additionally, tirzepatide, a dual GIP/GLP-1 receptor agonist, has gained prominence following USFDA approval in 2023 for weight management in adults with obesity or overweight and has demonstrated robust efficacy in RCTs
APPROACH Your IV Experience at GWCIM Step 1 Start with a Medical Appointment Before your first infusion, you'll meet with one of our physicians
Introduction Alzheimers disease (AD), a global public health priority, is the most common neurodegenerative disease (1)
After complete discontinuation, most individuals regain some weight
Why Liver Function Matters More Than Most People Realize Your liver isnt just some detox filter. It plays a huge role in how your body runs day to day, including things like energy, digestion, and overall balance